EE541 Cost-Effectiveness, Health-State Utility Values (HSUVs) and Cost and Resource Use (CRU) Associated with Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS): An Economic Systematic Literature Review (SLR)
Abstract
Authors
A. Papadakis-Sali A. Bobrowska S. Shaw E.J. Sabate Estrella Y. Asukai M. Radford